1. bookVolume 71 (2021): Issue 4 (December 2021)
Journal Details
License
Format
Journal
eISSN
1820-7448
First Published
25 Mar 2014
Publication timeframe
4 times per year
Languages
English
Open Access

Investigation of the Effects of L-carnitine and magnesium on Oxidative Stress and Cytokines in the Tissue of Experimental diabetic rats

Published Online: 30 Dec 2021
Volume & Issue: Volume 71 (2021) - Issue 4 (December 2021)
Page range: 477 - 489
Accepted: 08 Nov 2021
Journal Details
License
Format
Journal
eISSN
1820-7448
First Published
25 Mar 2014
Publication timeframe
4 times per year
Languages
English
Abstract

The aim of this study was to determine the effects of L-carnitine and magnesium on the levels of tissue malondialdehyde, 8-hydroxy-2’-deoxyguanosine, and cytokines (tumor necrosis factor alpha, interleukin-6) in streptozotocin-induced experimental diabetes in rats. Eighty male Wistar albino rats (200-250 g) were divided into 8 groups with 10 rats in each group. The groups received the following treatments: Control group; 2 ml distilled water (by gavage); Group 2: 50 mg/kg (b.w.) i.p. streptozotocin; Group 3: 125 mg/kg (b.w.) magnesium; Group 4: 300 mg/kg (b.w.) L-carnitine; Group 5: 125 mg/kg (b.w.) magnesium +300 mg/kg (b.w.) L-carnitine; Group 6: 50 mg/kg (b.w.) streptozotocin +125 mg/kg (b.w.) magnesium; Group 7: 50 mg/kg (b.w.) streptozotocin +300 mg/kg (b.w.) L-carnitine and Group 8: 50 mg/kg (b.w.) streptozotocin +125 mg/ kg (b.w.) magnesium+300 mg/kg (b.w.) L-carnitine administered for 4 weeks. Liver and kidney malondialdehyde, 8-hydroxy-2’-deoxyguanosine, tumor necrosis factor alpha and interleukin-6 levels did not change in the magnesium, L-carnitine, and magnesium + L-carnitine groups compared to the control. The highest levels of malondialdehyde, 8-hydroxy-2’-deoxyguanosine, tumor necrosis factor alpha and interleukin-6 were determined only in the group with diabetes (Group 2). Lipid peroxidation, DNA damage, and cytokine levels were significantly reduced in diabetic animals with the administration of magnesium and L-carnitine separately or in combination. Based on the obtained results it can be concluded that magnesium and L-carnitine may have antidiabetic effects, especially in combination.

Keywords

1. Rao BK, Kesavulu MM, Giri R, Rao CA: Antidiabetic and hypolipidemic effects of Momordica cymbal aria Hook. fruit powder in alloxan-diabetic rats. J Ethnopharmacol 1999, 67: 103-109.10.1016/S0378-8741(99)00004-5 Search in Google Scholar

2. Yılmaz S, Üstündağ B: The levels of pyruvate kinase activity in renal and hepatic tissues of rats with diabetes induced by streptozotocin. Turk J Vet Anim Sci 2002, 26: 549-553. Search in Google Scholar

3. Öztürk Y, Altan VM, Yıldızoğlu-Arı N: Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 1996, 48: 69-112. Search in Google Scholar

4. Altan N, Dinçel AS, Koca C: Diabetes Mellitus and Oxidative Stress. Turk J Biochem 2006, 31;51-56. Search in Google Scholar

5. Kangralkar VA, Patil SD, Bandivadekar RM: Oxidative stress and diabetes: a review. Int J Pharm Appl 2010, 1: 38-45. Search in Google Scholar

6. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19: 257-67.10.2337/diacare.19.3.257 Search in Google Scholar

7. Michael JC, James MC and Robbins Vinay K. The pancreas. In: Vinay K, Tucker C and Ramzi Sc (eds) Pathalogic Basis of Disease. San Diego: CA, 2000, 902-929. Search in Google Scholar

8. Laires MJ, Monteiro CP, Bicho M: Role of cellular magnesium in health and human disease. Front Biosci 2004, 9: 262-276.10.2741/1223 Search in Google Scholar

9. Tütüncü S, Dökmeci AH: L-carnitine. J Int Med Sci 2006, 2: 65-68. Search in Google Scholar

10. Elamin A, Tuvemo T: Magnesium and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1990, 10: 203-209.10.1016/0168-8227(90)90062-X Search in Google Scholar

11. McDowell, LR. Vitamins in animal and human nutrition. Ames, Iowa State University Press, 2000, 641-658.10.1002/9780470376911 Search in Google Scholar

12. Günther T, Schümann K,Vormann J: Tumor necrosis factor-α, prostanoids and immunoglobins in magnesium deficiency. Magnes Bull 1995, 17: 109-114. Search in Google Scholar

13. Olatunji LA, Soladoye AO: Effect of increased magnesium intake on plasma cholosterol, triglyceride and oxidative stres in alloxan-diabetic rats. Afr J Med Med Sci 2007, 36: 155-61. Search in Google Scholar

14. Nakagawa M, Oono H, Nishio A: Enhanced production of IL-1β and IL-6 following endotoxin challenge in rats with dietary magnesium deficiency. J Vet Med Sci 2001, 63: 467-469.10.1292/jvms.63.46711346186 Search in Google Scholar

15. Shaker ME, Houssen ME, Abo-Hashem EM, Ibrahim MT: Comparison of vitamin E, L-carnitine and melatonin in ameliorating carbon tetrachloride and diabetes induced hepatic oxidative stress. J Physiol Biochem 2009, 65: 225-233.10.1007/BF0318057520119817 Search in Google Scholar

16. Kuryl T, Debski B, Milczarek M, Bertrandt J, Klos A: Effect of carnitine and microelements (chromium and selenium) on fatty acids metabolism in healthy and type 1 diabetic rats. Probl Hig Epidemiol 2011, 92: 583-586. Search in Google Scholar

17. Abayomi AI, Adewoye EO, Olaleye SB, Salami AT: Effect of magnesium pre-treatment on alloxan induced hyperglycemia in rats. Afr Health Sci 2011, 11: 79-84. Search in Google Scholar

18. Hfaiedh N, Murat JC, Elfeki A: Compared ability of garlic (Allium sativum) extract or α– tocopherol + magnesium association to reduce metabolic disorders and oxidative stres in diabetic rats. Phytother Res 2011, 25: 821-827.10.1002/ptr.334421086547 Search in Google Scholar

19. Karabulut N. Deneysel diyabet oluşturulan ratlarda L-karnitin ve magnezyumun bazı biyokimyasal parametrelere etkileri (The effects of L-carnitine and magnesium on some biochemical parameters in experimental diabetic rats). PhD Thesis, University of Erciyes, Turkey, 2017. Search in Google Scholar

20. Panda S, Chakraborty M, Majumder P, Mazumder S, Das S, Haldar PK: Antidiabetic, antioxidant and anti-hyperlipidaemic activity of Cucumus callosus in streptozotocin-induced diabetic rats. IJPSR 2016, 7: 1978-1984. Search in Google Scholar

21. Dawud FA, Eze ED, Ardja AA, Isa AS, Jimoh A, Bashiru M, Malgwi IS: Ameliorative effects of vitamin C and zinc in alloxan-induced diabetes and oxidative stress in wistar rats. Curr Res J Biol Sci 2012, 4: 123-129. Search in Google Scholar

22. Aboonabi A, Rahmat A, Othman F: Antioxidant effect of pomegranate against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Toxicol Rep 2014, 915-922.10.1016/j.toxrep.2014.10.022559811128962304 Search in Google Scholar

23. Parvizi MR, Parviz M, Tavangar SM, Soltani N, Kadkhodaee M, SeifiB, Azizi Y, Keshavarz M: Protective effect of magnesium on renal function in STZ-induced diabetic rats. JDMDC 2014, 13; 2-9.10.1186/s40200-014-0084-3415661125197628 Search in Google Scholar

24. Aluwong T, Ayo JO, Kpukple A, Oladipo OO: Amelioration of hyperglycemia, oxidative stress and dyslipidaemia in alloxan-induced diabetic wistar rats treated with probiotic and vitamin C. Nutrients 2016, 8: 1-15.10.3390/nu8050151488265527164129 Search in Google Scholar

25. Mohan Y, Jesuthankaraj GN, Thangavelu NR: Antidiabetic and antioxidant properties of Triticum aestivum in streptozotocin-induced diabetic rats. Adv Pharmacol Sci Volume 2013; Article ID 716073, 9 pages.10.1155/2013/716073387666924416041 Search in Google Scholar

26. Abdelmageed ME, Shehatou GS, Abdelsalam RA, Suddek GM, Salem HA: Cinnamaldehyde ameliorates STZ-induced rat diabetes through modulation of IRS1/PI3K/AKT2 pathway and AGEs/RAGE interaction. Naunyn-Schmiedeberg’s Arch Pharmacol 2019, 392: 243-258.10.1007/s00210-018-1583-430460386 Search in Google Scholar

27. Alkan EE, Celik İ: The therapeutics effects and toxic risk of Heracleum persicum Desf. extract on streptozotocin-induced diabetic rats. Toxicol Rep 2018, 5: 919-926.10.1016/j.toxrep.2018.08.004613878530225197 Search in Google Scholar

28. Shanmugam KR, Mallikarjuna K, Nishanth K, Nishanth K, Kuo CH, Reddy KS: Protective effect of dietary ginger on antioxidant enzymes and oxidative damage in experimental diabetic rat tissues. Food Chem 2011, 124: 1436-1442.10.1016/j.foodchem.2010.07.104 Search in Google Scholar

29. Çoban FK, Liman R, Cigerci İH, İnce S: The antioxidant effect of boron on oxidative stress and DNA damage in diabetic rats. Fresenius Environ Bull 2015, 24: 4059-4066. Search in Google Scholar

30. Samarghandian S, Borji A,Farkhondeh T: Attenuation of oxidative stress and inflammation by portulacaoleracea in streptozotocin-induced diabetic rats. J Evid Based Complementary Altern Med 2017, 22: 562-566.10.1177/2156587217692491587126729228809 Search in Google Scholar

31. Alotaibi MR, Fatani AJ, Almnaizel AT, Ahmed MM, Abuohashish HM, Al-Rejaiea SS: In vivo assessment of combined effects of glibenclamide and losartan in diabetic rats. Med Princ Pract 2019, 28: 178-185.10.1159/000496104654591630537701 Search in Google Scholar

32. Maritim AC, Sanders RA, Watkins BJ: Diabetes, oxidative stress, and antioxidants. J Biochem Mol Toxicol 2003, 17: 24-37.10.1002/jbt.1005812616644 Search in Google Scholar

33. Liao YJ, Ueno M, Nakagawa T, Huang C, Kanenishi K, Onodera M, Sakamoto H: Oxidative damage in cerebral vessels of diabetic db/db mice. Diabetes Metab Res Rev 2005, 21: 554-559.10.1002/dmrr.57916021652 Search in Google Scholar

34. Hsieh RH, Lien LM, Lin SH, Chen CW, Cheng HJ, Cheng HH: Alleviation of oxidative damage in multiple tissues in rats with streptozotocin-induced diabetes by ricebranoil supplementation. Ann N Y Acad Sci 2005, 1042: 365-371.10.1196/annals.1338.06115965082 Search in Google Scholar

35. Park KS, Kim JH, Kim MS, Kim JM, Kim SK, Choi JY, Chung MH, Han B, Kim SY, Lee HK: Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats. Diabetes 2001, 50: 2837-2841.10.2337/diabetes.50.12.283711723068 Search in Google Scholar

36. Andican G, Burçak G: Oxidative damage to nuclear DNA in streptozotocin-diabetic rat liver. Clin Exp Pharmacol Physiol 2005, 32: 663-666.10.1111/j.0305-1870.2005.04247.x16120194 Search in Google Scholar

37. Leng B, Tanga F, Lua M, Zhanga Z, Wang H, Zhang Y: Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway. Life Sci 2018, 209: 111-121.10.1016/j.lfs.2018.07.05330081006 Search in Google Scholar

38. Wang-Fischer Y, Garyantes T: Improving the reliability and utility of streptozotocin-induced rat diabetic model. J Diabetes Res Volume 2018, Article ID 8054073, 14 pages.10.1155/2018/8054073617475130345315 Search in Google Scholar

39. Adam SH, Giribabu N, Rao PV, Sayem ASM, Arya A, Panichayupakaranant P, Korla PK, Salleh N: Rhinacanthin C ameliorates hyperglycaemia, hyperlipidemia and pancreatic destruction in streptozotocin-nicotinamide induced adult male diabetic rats. Eur J Pharmacol 2016, 771:173-90.10.1016/j.ejphar.2015.12.02826703866 Search in Google Scholar

40. Pradhan AD, Ridker PM: Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 2002, 23: 831-834.10.1053/euhj.2001.305212042000 Search in Google Scholar

41. Pandey M, Vijayakumar: Nutraceutical supplementation for diabetes. Int J Pharm Sci 2011, 3: 33-40. Search in Google Scholar

42. Mooradian AD, Morley JE: Micronutrient status in diabetes mellitus. Am J Clin Nutr 1987, 45: 877-895.10.1093/ajcn/45.5.8773554960 Search in Google Scholar

43. Siddiqui K, Bawazeer N, Joy SS: Variation in macro and trace elements in proggression of type 2 diabetes. Sci Worl J Volume 2014, Article ID 461591, 9 pages.10.1155/2014/461591413888925162051 Search in Google Scholar

44. Hans CP, Chaudhary DP, Bansal DD: Effect of magnesium supplementation on oxidative stres in alloxanic diabetic rats. Magnes Res 2003, 16: 13-19. Search in Google Scholar

45. Sugimoto J, Romani AM, Valentin-Torres AM, Luciano AA, Kitchen RCM, Funderburg N, Mesiano S, Bernstein HB: Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. J Immunol 2012, 188: 6338-6346.10.4049/jimmunol.1101765388451322611240 Search in Google Scholar

46. Xia J, Chen H, Yan J, Wu H, Wang H, Guo J, Zhang X, Zhang S, Zhao Changli, Chen Y: High-purity magnesium staples suppress inflammatory response in rectal anastomoses. ACS Appl Mater Interfaces 2017, 9: 9506-9515.10.1021/acsami.7b0081328240546 Search in Google Scholar

47. Bieber LL: Carnitine. Annu Rev Biochem 1988, 57: 261-283.10.1146/annurev.bi.57.070188.0014013052273 Search in Google Scholar

48. Kerner J, Hoppel C: Genetic disorders of carnitine metabolism and their nutritional management. Annu Rev Nutr 1998, 18: 179-206.10.1146/annurev.nutr.18.1.1799706223 Search in Google Scholar

49. Flanagan JL, Simmons PA, Vehige J, Willcox MDP, Garrett Q: Role of carnitine in disease. Nutr Metab 2010; 7: 1-14. Search in Google Scholar

50. Sayılan Özgün G, Özgün E, Eskiocak S, Süt N: The effect of L-carnitine on nitric oxide metabolism in streptozotocin-induced diabetic rats. Turk J Biochem 2014, 39: 416-421.10.5505/tjb.2014.04934 Search in Google Scholar

51. Mansour HH. Effect of L-carnitine on endothelial dysfunction markers in diabetic-irradiated rats. Int J Toxicol Appl Pharmacol 2013, 3: 1-9. Search in Google Scholar

52. Al-Malki AL, Moselhy SS: Free fatty acids profiling in response to carnitine synergize with lutein in diabetic rats. Afr J Tradit Complement Altern Med 2016, 13: 149-154.10.21010/ajtcam.v13i6.21541218628480372 Search in Google Scholar

53. Uysal N, Yalaz G, Acikgoz O, Gonenc S, Kayatekin BM: Effects of L-carnitine on diabetogenic action of streptozotocin in rats. Neuro Endocrinol Lett 2005, 26: 419-422. Search in Google Scholar

54. Calo LA, Pagnin E, Davis PA, Semplicini A, Nicolai R, Calvani M, Pessina AC: Antioxidant effect of L-carnitine and its short chain esters: relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol 2006, 107: 54-60.10.1016/j.ijcard.2005.02.05316337498 Search in Google Scholar

55. Hamdy R, Salama M: Hypoglycemic effect of lipoic acid, carnitine and Nigella Sativa in diabetic rat model. Int J Health Sci 2011, 5: 126–134. Search in Google Scholar

56. Zheng H, Piao S, Sun L, Zhao H, Jin J, Jin J, Yang C, Li C: Renoprotective effects of L-carnitine in streptozotocin-induced diabetic nephropathy. Int J Clin Exp Med 2018, 1: 4459-4469. Search in Google Scholar

57. Evangeliou A, Vlassopoulos D: Carnitine metabolism and deficit-when supplementation is necessary? Curr Pharm Biotechnol 2003, 4: 211-219.10.2174/138920103348982912769764 Search in Google Scholar

58. Komlosi K, Havasi V, Bene J, Süle N, Pajor L, Nicolai R, Benatti P, Calvani M, Melegh B: Histopathologic abnormalities of the lymphoreticular tissues in organic cation transporter 2 deficiency: evidence for impaired B cell maturation. J Pediatr 2007, 150: 109-111.10.1016/j.jpeds.2006.09.04217188629 Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo